Literature DB >> 18263810

Occludin independently regulates permeability under hydrostatic pressure and cell division in retinal pigment epithelial cells.

Brett E Phillips1, Limary Cancel, John M Tarbell, David A Antonetti.   

Abstract

PURPOSE: The aim of this study was to determine the function of the tight junction protein occludin in the control of permeability, under diffusive and hydrostatic pressures, and its contribution to the control of cell division in retinal pigment epithelium.
METHODS: Occludin expression was inhibited in the human retinal pigment epithelial cell line ARPE-19 by siRNA. Depletion of occludin was confirmed by Western blot, confocal microscopy, and RT-PCR. Paracellular permeability of cell monolayers to fluorescently labeled 70 kDa dextran, 10 kDa dextran, and 467 Da tetramethylrhodamine (TAMRA) was examined under diffusive conditions or after the application of 10 cm H2O transmural pressure. Cell division rates were determined by tritiated thymidine incorporation and Ki67 immunoreactivity. Cell cycle inhibitors were used to determine whether changes in cell division affected permeability.
RESULTS: Occludin depletion increased diffusive paracellular permeability to 467 Da TAMRA by 15%, and permeability under hydrostatic pressure was increased 50% compared with control. Conversely, depletion of occludin protein with siRNA did not alter diffusive permeability to 70 kDa and 10 kDa RITC-dextran, and permeability to 70 kDa dextran was twofold lower in occludin-depleted cells under hydrostatic pressure conditions. Occludin depletion also increased thymidine incorporation by 90% and Ki67-positive cells by 50%. Finally, cell cycle inhibitors did not alter the effect of occludin siRNA on paracellular permeability.
CONCLUSIONS: The data suggest that occludin regulates tight junction permeability in response to changes in hydrostatic pressure. Furthermore, these data suggest that occludin also contributes to the control of cell division, demonstrating a novel function for this tight junction protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263810      PMCID: PMC2483238          DOI: 10.1167/iovs.07-1204

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

1.  Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing.

Authors:  F Lacaz-Vieira; M M Jaeger; P Farshori; B Kachar
Journal:  J Membr Biol       Date:  1999-04-01       Impact factor: 1.843

Review 2.  Molecular architecture of tight junctions.

Authors:  L L Mitic; J M Anderson
Journal:  Annu Rev Physiol       Date:  1998       Impact factor: 19.318

3.  Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin.

Authors:  Asma Nusrat; G Thomas Brown; Jeffrey Tom; Alex Drake; Tam T T Bui; Cliff Quan; Randall J Mrsny
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

4.  High-throughput mapping of a dynamic signaling network in mammalian cells.

Authors:  Miriam Barrios-Rodiles; Kevin R Brown; Barish Ozdamar; Rohit Bose; Zhong Liu; Robert S Donovan; Fukiko Shinjo; Yongmei Liu; Joanna Dembowy; Ian W Taylor; Valbona Luga; Natasa Przulj; Mark Robinson; Harukazu Suzuki; Yoshihide Hayashizaki; Igor Jurisica; Jeffrey L Wrana
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

5.  Epithelial transport and barrier function in occludin-deficient mice.

Authors:  J D Schulzke; A H Gitter; J Mankertz; S Spiegel; U Seidler; S Amasheh; M Saitou; S Tsukita; M Fromm
Journal:  Biochim Biophys Acta       Date:  2005-05-15

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

Authors:  D A Antonetti; A J Barber; S Khin; E Lieth; J M Tarbell; T W Gardner
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

8.  The tight junction protein occludin and the adherens junction protein alpha-catenin share a common interaction mechanism with ZO-1.

Authors:  Sebastian L Müller; Michael Portwich; Anke Schmidt; Darkhan I Utepbergenov; Otmar Huber; Ingolf E Blasig; Gerd Krause
Journal:  J Biol Chem       Date:  2004-11-16       Impact factor: 5.157

9.  Occludin is a functional component of the tight junction.

Authors:  K M McCarthy; I B Skare; M C Stankewich; M Furuse; S Tsukita; R A Rogers; R D Lynch; E E Schneeberger
Journal:  J Cell Sci       Date:  1996-09       Impact factor: 5.285

10.  Occludin as a possible determinant of tight junction permeability in endothelial cells.

Authors:  T Hirase; J M Staddon; M Saitou; Y Ando-Akatsuka; M Itoh; M Furuse; K Fujimoto; S Tsukita; L L Rubin
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

View more
  17 in total

1.  Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction.

Authors:  Paul M Titchenell; Cheng-Mao Lin; Jason M Keil; Jeffrey M Sundstrom; Charles D Smith; David A Antonetti
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

2.  Occludin localizes to centrosomes and modifies mitotic entry.

Authors:  E Aaron Runkle; Jeffrey M Sundstrom; Kristin B Runkle; Xuwen Liu; David A Antonetti
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

3.  Native matrix-based human lung alveolar tissue model in vitro: studies of the reparatory actions of mesenchymal stem cells.

Authors:  Ieva Bruzauskaite; Jovile Raudoniute; Jaroslav Denkovskij; Edvardas Bagdonas; Sandra Meidute-Abaraviciene; Vaida Simonyte; Daiva Bironaite; Almantas Siaurys; Eiva Bernotiene; Ruta Aldonyte
Journal:  Cytotechnology       Date:  2016-12-01       Impact factor: 2.058

4.  Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.

Authors:  Ahmed S Ibrahim; Amany M Tawfik; Khaled A Hussein; Sally Elshafey; Shanu Markand; Nasser Rizk; Elia J Duh; Sylvia B Smith; Mohamed Al-Shabrawey
Journal:  Biochim Biophys Acta       Date:  2015-01-03

5.  Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO.

Authors:  Jason M Keil; Xuwen Liu; David A Antonetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-12       Impact factor: 4.799

6.  Meprin A impairs epithelial barrier function, enhances monocyte migration, and cleaves the tight junction protein occludin.

Authors:  Jialing Bao; Renee E Yura; Gail L Matters; S Gaylen Bradley; Pan Shi; Fang Tian; Judith S Bond
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

7.  Ambient particulate matter affects occludin distribution and increases alveolar transepithelial electrical conductance.

Authors:  Juan C Caraballo; Cecilia Yshii; Whitney Westphal; Thomas Moninger; Alejandro P Comellas
Journal:  Respirology       Date:  2011-02       Impact factor: 6.424

Review 8.  Tight junction proteins: from barrier to tumorigenesis.

Authors:  E Aaron Runkle; David Mu
Journal:  Cancer Lett       Date:  2013-06-03       Impact factor: 8.679

9.  Knockdown of sodium-calcium exchanger 1 induces epithelial-to-mesenchymal transition in kidney epithelial cells.

Authors:  Sona Lakshme Balasubramaniam; Anilkumar Gopalakrishnapillai; Nicholas J Petrelli; Sonali P Barwe
Journal:  J Biol Chem       Date:  2017-05-26       Impact factor: 5.157

10.  Occludin S471 Phosphorylation Contributes to Epithelial Monolayer Maturation.

Authors:  Mark T Bolinger; Aniket Ramshekar; Helen V Waldschmidt; Scott D Larsen; Maria C Bewley; John M Flanagan; David A Antonetti
Journal:  Mol Cell Biol       Date:  2016-07-14       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.